Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
While the studies published to date have limitations, there are several ongoing investigations, including the pivotal FOCUS trial, conducted as a post-authorization safety commitment to the European Medicines Agency
Low potassium (hypokalemia): Muscle weakness, cramping, or irregular heartbeat, particularly early in treatment
Coverage for the OSA indication, which the FDA approved in late 2024, remains uneven
First order went great
The pooling of the blood in the legs can break the valve in the vein and cause engorgement of the vein
US$ 23.43
US$ 25.12
US$ 25.36
US$ 23.25
US$ 28.98
